Elsevier Inc.

SHERPA: Unknown

People

  1. Zelefsky
    Zelefsky
  2. Giralt
    Giralt
  3. Wolden
    Wolden
  4. Abu-Rustum
    Abu-Rustum
  5. Lee
    Lee
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Jakubowski
    Jakubowski
  9. Gardner
    Gardner
  10. Yahalom
    Yahalom

Groups

  1. Survivorship Research (2658)
  2. Department of Medicine (1297)
  3. Surgery (983)
  4. Radiation Oncology, Department of (878)
  5. Center for Hematologic Malignancies (685)
  6. Solid Tumor Oncology Division (673)
  7. Epidemiology and Biostatistics (592)
  8. Population Sciences Research Program (525)
  9. Hematologic Malignancies, Division of (509)
  10. Gynecology Disease Management Team (496)
Search Within
  1. "Survivorship Research"
Formats
  1. Journal Article (1281)
  2. Meeting Abstract (1193)
  3. Review (61)
  4. Editorial (44)
  5. Book Section (35)
  6. Conference Paper (14)
  7. Correspondence (13)
  8. Research Letter (9)
  9. Guidelines (6)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Survivorship Research (2658)
  2. Department of Medicine (1297)
  3. Surgery (983)
  4. Radiation Oncology, Department of (878)
  5. Center for Hematologic Malignancies (685)
  6. Solid Tumor Oncology Division (673)

More Groups

People
  1. Michael Zelefsky (401)
  2. Sergio Giralt (268)
  3. Suzanne Wolden (233)
  4. Nadeem Abu-Rustum (202)
  5. Nancy Lee (195)
  6. Miguel-Angel Perales (172)

More People

Years
  1. 2025 (36)
  2. 2024 (130)
  3. 2023 (143)
  4. 2022 (159)
  5. 2021 (139)
  6. 2020 (192)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (908)
  2. Gynecologic Oncology (285)
  3. Biology of Blood and Marrow Transplantation (275)
  4. Journal of Thoracic Oncology (124)
  5. Clinical Lymphoma, Myeloma and Leukemia (85)
  6. European Journal of Cancer (62)

More Publications

Results (2658)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline mutations in a large cohort of multiple myeloma
    Meeting Abstract

    Conry, M.; Camp, N.; Vachon, C.; Slager, S.; Hildebrandt, M.; Brown, E.; Garber, J.; Norman, A.; Stokes, S.; Lipkin, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for patients with three-year sustained MRD negative remissions: Initial results from a phase II study
    Meeting Abstract

    Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Chemotherapy signatures reveal the evolutionary history of post-melphalan myeloid neoplasm
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Coffey, D.; Lu, S.; Bolli, N.; Bolton, K.; Park, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • The impact of bowel preparation on surgical site infection rates in gynecologic oncology surgery, post-hoc analysis from a randomized controlled trial
    Meeting Abstract

    Moukarzel, L.; Nguyen, N.; Zhou, Q.; Ramesh, B.; Chi, D.; Sonoda, Y.; Brown, A.; Abu-Rustum, N.; Mueller, J.; Roche, K. L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Evidence-based guidelines increase uptake and decrease racial disparities in endometrioid endometrial cancer patients electing ovarian preservation
    Meeting Abstract

    Manning-Geist, B.; Rios-Doria, E.; Aviki, E.; Zhou, Q.; Abu-Rustum, N.; Brown, C.; Mueller, J.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Chi, D.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; O'Cearbhaill, R.; Zivanovic, O.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Oncologic outcomes of secondary cytoreductive surgery in the era of poly (ADP-ribose) polymerase inhibitors maintenance
    Meeting Abstract

    Ehmann, S.; Lam, C.; Zhou, Q.; Grisham, R.; Roche, K. L.; Zivanovic, O.; Sonoda, Y.; Chi, D.; Gardner, G.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • What matters most in FIGO IIIA endometrial cancer: Involvement of serosa, adnexa, or both?
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Glaser, G.; McGree, M.; Eriksson, A. G. Z.; Pham, M.; Soliman, P.; Ataseven, B.; Alektiar, K.; Zamarin, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy compared with systematic lymphadenectomy in patients with uterine carcinosarcoma
    Meeting Abstract

    Zammarrelli, W.; Greenman, M.; Rios-Doria, E.; Miller, K.; Broach, V.; Mueller, J.; Aviki, E.; Abu-Rustum, N.; Leitao, M.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular and pathologic data can guide selection of endometrioid endometrial cancer patients for ovarian preservation
    Meeting Abstract

    Manning-Geist, B.; Rios-Doria, E.; Liu, Y.; Ellenson, L.; Zhou, Q.; Leitao, M.; Abu-Rustum, N.; Weigelt, B.; Mueller, J.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save